Slovenian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
hepatitis/slabost navzea
Povezava se shrani v odložišče
Stran 1 iz 735 rezultatov
Radiology case of the month. Nausea, vomiting, and diarrhea in a patient with hepatitis C and acquired immunodeficiency syndrome (AIDS). Diffuse, severe gastric-wall thickening, consistent with edema.
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
The patient is a 42-year-old male with a past medical history of HIV/AIDS (his most recent CD4 count, four months before admission, was 19) and hepatitis C who presented to the Emergency Department complaining of one week of persistent nausea, vomiting, and diarrhea. His admit labs were as follows:
Evaluation of oral cannabinoid-containing medications for the management of interferon and ribavirin-induced anorexia, nausea and weight loss in patients treated for chronic hepatitis C virus.
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
OBJECTIVE
The systemic and cognitive side effects of hepatitis C virus (HCV) therapy may be incapacitating, necessitating dose reductions or abandonment of therapy. Oral cannabinoid-containing medications (OCs) ameliorate chemotherapy-induced nausea and vomiting, as well as AIDS wasting syndrome.
Adding ribavirin to interferon alpha-2b for chronic hepatitis C infection increased virological response and nausea.
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
Hepatitis B virus infection in an HBsAb-positive lymphoma patient who received chemotherapy: A case report.
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
BACKGROUND
Tumor chemotherapy could weaken the immune system of patients, which might enhance the body sensitivities to the exogenous pathogens, among which the hepatitis B virus (HBV) infection should be concerned because of the higher chances of infection and the severe outcomes, especially in
Acute Viral Hepatitis.
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
The mainstay of treatment for acute viral hepatitis is supportive care, as most cases are self-limited. General measures in all types of acute viral hepatitis include bedrest if the patient is very symptomatic, a high-calorie diet, avoidance of hepatotoxic medications, and abstinence from alcohol
Hepatitis A Virus: Essential Knowledge and a Novel Identify-Isolate-Inform Tool for Frontline Healthcare Providers.
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
Infection with hepatitis A virus (HAV) causes a highly contagious illness that can lead to serious morbidity and occasional mortality. Although the overall incidence of HAV has been declining since the introduction of the HAV vaccine, there have been an increasing number of outbreaks within the
Australian women's experiences of living with hepatitis C virus: results from a cross-sectional survey.
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
BACKGROUND
Of the estimated 160000 Australians currently infected with the hepatitis C virus (HCV), over one-third are women and very few have received clinical treatment, with most managing their illness in non-specialist settings. Little is known about the experiences of women living with HCV in
Australian men's experiences of living with hepatitis C virus: results from a cross-sectional survey.
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
OBJECTIVE
Of the estimated 160,000 Australians currently infected with hepatitis C virus (HCV), two-thirds are men. Little is known about their social and health needs. The present study presents results from a comprehensive survey of Australian men living with HCV.
METHODS
In 2002, a
Hepatitis A and HIV: a clinical review of disease and strategies for prevention.
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
Hepatitis A, also known as infectious hepatitis, remains one of the more commonly transmitted types of viral hepatitis in the United States. Given the high prevalence of this illness, clinicians need to be aware not only about the clinical manifestations of this disease, but also about the special
Twenty-four vs. forty-eight weeks of re-therapy with interferon alpha 2b and ribavirin in interferon alpha monotherapy relapsers with chronic hepatitis C.
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
OBJECTIVE
Roughly 50% of patients with chronic hepatitis C, who relapsed after a previous monotherapy with interferon alpha, will respond in a sustained fashion to 24 weeks of re-therapy with the combination of interferon alpha plus ribavirin. Whether prolonging treatment duration to 48 weeks will
Disulfiram-induced hepatitis.
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
We reported a case of disulfiram-induced hepatitis with unique clinical features and compared our case with others in the literature. Our patient had headache, mild fever, nausea, vomiting, rash, and eosinophilia after 3 weeks of disulfiram therapy. Subsequent liver biopsy showed low-grade lobular
Ticlopidine-induced severe cholestatic hepatitis.
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
We report a case study of an 86-year-old female patient with severe cholestatic hepatitis who was undergoing treatment with oral ticlopidine 250 mg daily for coronary artery disease. The patient had nausea and vomiting and was jaundiced after taking ticlopidine for 6 weeks. She was admitted to the
An open-label study of administration of EH0202, a health-food additive, to patients with chronic hepatitis C.
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
BACKGROUND
In this study, we examined the effect of EH0202, a mixture of four herbal extracts that are known to induce interferons, on hepatitis C virus (HCV)-RNA levels in patients with chronic hepatitis C.
METHODS
This was an open-label uncontrolled study. The study subjects ingested food
[Hepatitis A - combined prolonged biphasic and cholestatic course of disease].
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
METHODS
One month after a first manifestation of a hepatitis A infection and transaminases had become normal, a 44-year-old woman again became jaundiced with accompanied by weakness, nausea and nocturnal sweating.
METHODS
Laboratory tests again showed features of hepatitis with decreased synthetic
Ribavirin in acute viral hepatitis.
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
Sixty-four patients suffering from acute viral hepatitis (excluding those suffering from hepatitis B) were selected for the double blind clinical trial. They were randomly allocated to either ribavirin therapy (200 mg four times a day) or placebo. Four patients were lost to follow up and therefore
Najbolj popolna baza zdravilnih zelišč, podprta z znanostjo
- Deluje v 55 jezikih
- Zeliščna zdravila, podprta z znanostjo
- Prepoznavanje zelišč po sliki
- Interaktivni GPS zemljevid - označite zelišča na lokaciji (kmalu)
- Preberite znanstvene publikacije, povezane z vašim iskanjem
- Iščite zdravilna zelišča po njihovih učinkih
- Organizirajte svoje interese in bodite na tekočem z raziskavami novic, kliničnimi preskušanji in patenti
Vnesite simptom ali bolezen in preberite o zeliščih, ki bi lahko pomagala, vnesite zelišče in si oglejte bolezni in simptome, proti katerim se uporablja.
* Vse informacije temeljijo na objavljenih znanstvenih raziskavah
